Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1996 Mar;64(3):782–790. doi: 10.1128/iai.64.3.782-790.1996

Intracellular survival of Burkholderia pseudomallei.

A L Jones 1, T J Beveridge 1, D E Woods 1
PMCID: PMC173838  PMID: 8641782

Abstract

Burkholderia pseudomallei is the causative agent of melioidosis, a disease being increasingly recognized as an important cause of morbidity and mortality in many regions of the world. Several features of melioidosis suggest that B. pseudomallei is a facultative intracellular pathogen. This study was designed to assess the ability of B. pseudomallei to invade and survive in eukaryotic cells. We have shown that B. pseudomallei has the capacity to invade cultured cell lines, including HeLa, CHO, A549, and Vero cells. We have demonstrated intracellular survival of B. pseudomallei in professional phagocytic cells, including rat alveolar macrophages. B pseudomallei was localized inside vacuoles in human monocyte-like U937 cells, a histiocytic lymphoma cell line with phagocytic properties. Additionally, electron microscopic visualization of B. pseudomallei-infected HeLa cells and polymorphonuclear leukocytes confirmed the presence of intracellular bacteria within membrane-bound vacuoles. B. pseudomallei was found to be resistant to the cationic peptide protamine and to purified human defensin HNP-1.

Full Text

The Full Text of this article is available as a PDF (3.3 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ashdown L. R., Koehler J. M. Production of hemolysin and other extracellular enzymes by clinical isolates of Pseudomonas pseudomallei. J Clin Microbiol. 1990 Oct;28(10):2331–2334. doi: 10.1128/jcm.28.10.2331-2334.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Chaowagul W., White N. J., Dance D. A., Wattanagoon Y., Naigowit P., Davis T. M., Looareesuwan S., Pitakwatchara N. Melioidosis: a major cause of community-acquired septicemia in northeastern Thailand. J Infect Dis. 1989 May;159(5):890–899. doi: 10.1093/infdis/159.5.890. [DOI] [PubMed] [Google Scholar]
  3. Cooper J. A. Effects of cytochalasin and phalloidin on actin. J Cell Biol. 1987 Oct;105(4):1473–1478. doi: 10.1083/jcb.105.4.1473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dabiri G. A., Sanger J. M., Portnoy D. A., Southwick F. S. Listeria monocytogenes moves rapidly through the host-cell cytoplasm by inducing directional actin assembly. Proc Natl Acad Sci U S A. 1990 Aug;87(16):6068–6072. doi: 10.1073/pnas.87.16.6068. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Daher K. A., Lehrer R. I., Ganz T., Kronenberg M. Isolation and characterization of human defensin cDNA clones. Proc Natl Acad Sci U S A. 1988 Oct;85(19):7327–7331. doi: 10.1073/pnas.85.19.7327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Dance D. A. Melioidosis: the tip of the iceberg? Clin Microbiol Rev. 1991 Jan;4(1):52–60. doi: 10.1128/cmr.4.1.52. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Densen P., Mandell G. L. Phagocyte strategy vs. microbial tactics. Rev Infect Dis. 1980 Sep-Oct;2(5):817–838. doi: 10.1093/clinids/2.5.817. [DOI] [PubMed] [Google Scholar]
  8. Desmarchelier P. M., Dance D. A., Chaowagul W., Suputtamongkol Y., White N. J., Pitt T. L. Relationships among Pseudomonas pseudomallei isolates from patients with recurrent melioidosis. J Clin Microbiol. 1993 Jun;31(6):1592–1596. doi: 10.1128/jcm.31.6.1592-1596.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Elsinghorst E. A. Measurement of invasion by gentamicin resistance. Methods Enzymol. 1994;236:405–420. doi: 10.1016/0076-6879(94)36030-8. [DOI] [PubMed] [Google Scholar]
  10. Fields P. I., Swanson R. V., Haidaris C. G., Heffron F. Mutants of Salmonella typhimurium that cannot survive within the macrophage are avirulent. Proc Natl Acad Sci U S A. 1986 Jul;83(14):5189–5193. doi: 10.1073/pnas.83.14.5189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Ganz T., Selsted M. E., Lehrer R. I. Defensins. Eur J Haematol. 1990 Jan;44(1):1–8. doi: 10.1111/j.1600-0609.1990.tb00339.x. [DOI] [PubMed] [Google Scholar]
  12. Ganz T., Selsted M. E., Szklarek D., Harwig S. S., Daher K., Bainton D. F., Lehrer R. I. Defensins. Natural peptide antibiotics of human neutrophils. J Clin Invest. 1985 Oct;76(4):1427–1435. doi: 10.1172/JCI112120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Garcia Véscovi E., Soncini F. C., Groisman E. A. The role of the PhoP/PhoQ regulon in Salmonella virulence. Res Microbiol. 1994 Jun-Aug;145(5-6):473–480. doi: 10.1016/0923-2508(94)90096-5. [DOI] [PubMed] [Google Scholar]
  14. Green R. N., Tuffnell P. G. Laboratory acquired melioidosis. Am J Med. 1968 Apr;44(4):599–605. doi: 10.1016/0002-9343(68)90060-0. [DOI] [PubMed] [Google Scholar]
  15. Groisman E. A., Parra-Lopez C., Salcedo M., Lipps C. J., Heffron F. Resistance to host antimicrobial peptides is necessary for Salmonella virulence. Proc Natl Acad Sci U S A. 1992 Dec 15;89(24):11939–11943. doi: 10.1073/pnas.89.24.11939. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. HECKLY R. J., NIGG C. Toxins of Pseudomonas pseudomallei. II. Characterization. J Bacteriol. 1958 Oct;76(4):427–436. doi: 10.1128/jb.76.4.427-436.1958. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Harwig S. S., Ganz T., Lehrer R. I. Neutrophil defensins: purification, characterization, and antimicrobial testing. Methods Enzymol. 1994;236:160–172. doi: 10.1016/0076-6879(94)36015-4. [DOI] [PubMed] [Google Scholar]
  18. Howe C., Sampath A., Spotnitz M. The pseudomallei group: a review. J Infect Dis. 1971 Dec;124(6):598–606. doi: 10.1093/infdis/124.6.598. [DOI] [PubMed] [Google Scholar]
  19. Kalmar J. R. Measurement of opsonic phagocytosis by human polymorphonuclear neutrophils. Methods Enzymol. 1994;236:108–119. doi: 10.1016/0076-6879(94)36011-1. [DOI] [PubMed] [Google Scholar]
  20. Kaufmann S. H. Immunity to intracellular bacteria. Annu Rev Immunol. 1993;11:129–163. doi: 10.1146/annurev.iy.11.040193.001021. [DOI] [PubMed] [Google Scholar]
  21. Kingston C. W. Chronic or latent melioidosis. Med J Aust. 1971 Sep 18;2(12):618–621. doi: 10.5694/j.1326-5377.1971.tb92445.x. [DOI] [PubMed] [Google Scholar]
  22. Koponen M. A., Zlock D., Palmer D. L., Merlin T. L. Melioidosis. Forgotten, but not gone! Arch Intern Med. 1991 Mar;151(3):605–608. doi: 10.1001/archinte.151.3.605. [DOI] [PubMed] [Google Scholar]
  23. Lieber M., Smith B., Szakal A., Nelson-Rees W., Todaro G. A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells. Int J Cancer. 1976 Jan 15;17(1):62–70. doi: 10.1002/ijc.2910170110. [DOI] [PubMed] [Google Scholar]
  24. Mackowiak P. A., Smith J. W. Septicemic melioidosis. Occurrence following acute influenza A six years after exposure in Vietnam. JAMA. 1978 Aug 25;240(8):764–766. doi: 10.1001/jama.240.8.764. [DOI] [PubMed] [Google Scholar]
  25. Mays E. E., Ricketts E. A. Melioidosis: recrudescence associated with bronchogenic carcinoma twenty-six years following initial geographic exposure. Chest. 1975 Aug;68(2):261–263. doi: 10.1378/chest.68.2.261. [DOI] [PubMed] [Google Scholar]
  26. Pruksachartvuthi S., Aswapokee N., Thankerngpol K. Survival of Pseudomonas pseudomallei in human phagocytes. J Med Microbiol. 1990 Feb;31(2):109–114. doi: 10.1099/00222615-31-2-109. [DOI] [PubMed] [Google Scholar]
  27. Rest R. F., Speert D. P. Measurement of nonopsonic phagocytic killing by human and mouse phagocytes. Methods Enzymol. 1994;236:91–108. doi: 10.1016/0076-6879(94)36010-3. [DOI] [PubMed] [Google Scholar]
  28. Rosenshine I., Ruschkowski S., Finlay B. B. Inhibitors of cytoskeletal function and signal transduction to study bacterial invasion. Methods Enzymol. 1994;236:467–476. doi: 10.1016/0076-6879(94)36035-9. [DOI] [PubMed] [Google Scholar]
  29. Sexton M. M., Goebel L. A., Godfrey A. J., Choawagul W., White N. J., Woods D. E. Ribotype analysis of Pseudomonas pseudomallei isolates. J Clin Microbiol. 1993 Feb;31(2):238–243. doi: 10.1128/jcm.31.2.238-243.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Yang H. M., Chaowagul W., Sokol P. A. Siderophore production by Pseudomonas pseudomallei. Infect Immun. 1991 Mar;59(3):776–780. doi: 10.1128/iai.59.3.776-780.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. van Oss C. J. Phagocytosis: an overview. Methods Enzymol. 1986;132:3–15. doi: 10.1016/s0076-6879(86)32003-2. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES